One study reported 59.6% of melanoma biopsies being measured by Melan-A stain as having a greater depth of tumour invasion than was measured by H&E, which led to 33% cases of melanoma in situ to be re-classified as invasive melanoma [84]. The gene discussed is MLANA; the disease is neoplasm.